Sandy Spring Bank trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,681 shares of the pharmacy operator’s stock after selling 2,466 shares during the quarter. Sandy Spring Bank’s holdings in Walgreens Boots Alliance were worth $2,089,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Hudock Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Reilly Financial Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after acquiring an additional 100 shares during the period. Orrstown Financial Services Inc. lifted its stake in shares of Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 213 shares during the period. Private Vista LLC lifted its stake in shares of Walgreens Boots Alliance by 6,403.7% in the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after acquiring an additional 574,218 shares during the period. Finally, Hanson McClain Inc. lifted its stake in shares of Walgreens Boots Alliance by 4.6% in the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after acquiring an additional 87 shares during the period. 63.58% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This piece was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/11/14/sandy-spring-bank-sells-2466-shares-of-walgreens-boots-alliance-inc-wba.html.

In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The stock was purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 13.50% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at $70.37 on Tuesday. Walgreens Boots Alliance, Inc. has a 1-year low of $63.82 and a 1-year high of $88.00. The stock has a market capitalization of $71,667.88, a price-to-earnings ratio of 13.92, a P/E/G ratio of 1.26 and a beta of 1.20. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the prior year, the company posted $1.07 earnings per share. Walgreens Boots Alliance’s revenue was up 5.3% compared to the same quarter last year. analysts forecast that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.27%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.

Walgreens Boots Alliance declared that its Board of Directors has initiated a share repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

A number of equities analysts recently commented on the company. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday. UBS AG reaffirmed a “buy” rating and issued a $96.00 price objective (down from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Royal Bank Of Canada assumed coverage on Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective on the stock. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. Finally, Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Monday, October 30th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and an average price target of $87.63.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.